Cargando…

Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?

Detalles Bibliográficos
Autores principales:	Espírito-Santo, Sheila, Coutinho, Vinícius Gabriel, Gomes, Flávia Carvalho Alcantara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241403/ https://www.ncbi.nlm.nih.gov/pubmed/35799527 http://dx.doi.org/10.4103/1673-5374.340407

Ejemplares similares

Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023)

Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease
por: Seiler, Stefanie, et al.
Publicado: (2015)

Nogo-A and the regulation of neurotransmitter receptors
por: Tang, Bor Luen
Publicado: (2020)

Trans-synaptic degeneration as a mechanism of neurodegeneration in multiple sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2023)

Neuron-to-astrocyte proteostatic stress signaling in response to tau pathology
por: Batenburg, Kevin Llewelyn, et al.
Publicado: (2023)

Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis
por: Teng, Felicia Yu Hsuan, et al.
Publicado: (2008)

LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth
por: Kurihara, Yuji, et al.
Publicado: (2015)

Counteraction of Nogo-A and axonal growth inhibitors by green tea polyphenols and other natural products
por: Fan, Tiffany K., et al.
Publicado: (2016)

Nogo-A receptor internalization by cyclic adenosine monophosphate in overcoming axonal growth inhibitors after stroke
por: Gopalakrishna, Rayudu, et al.
Publicado: (2021)

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Astrocyte Heterogeneity: Impact to Brain Aging and Disease
por: Matias, Isadora, et al.
Publicado: (2019)

Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery
por: Jitsuki, Susumu, et al.
Publicado: (2016)

Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
por: De Kleijn, Kim M. A., et al.
Publicado: (2021)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Multiple reaction monitoring for the detection of disease-related synaptic proteins
por: Chang, Rachel Yoon Kyung, et al.
Publicado: (2014)

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson’s disease
por: Banks, Susan M.L., et al.
Publicado: (2020)

Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis
por: Skundric, Dusanka S.
Publicado: (2015)

Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model
por: Ye, Sining, et al.
Publicado: (2023)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age
por: Kragness, S., et al.
Publicado: (2022)

Locomotion Induces Fundamentally Different Patterns of Ca(2+) Signaling in Astrocytes and Neurons
por: Hirase, Hajime, et al.
Publicado: (2023)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
por: Nobili, Paola, et al.
Publicado: (2022)

Lateral olfactory tract usher substance (LOTUS) protein, an endogenous Nogo receptor antagonist, converts a non-permissive to permissive brain environment for axonal regrowth
por: Hirokawa, Tomoko, et al.
Publicado: (2018)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Light of the stars: calcium signals light up astrocytes in the presence of autoreactive CD4(+) T cells
por: Bogdanović Pristov, Jelena, et al.
Publicado: (2021)

Functional imaging of astrocyte activity
por: Kato, Hiroki, et al.
Publicado: (2020)

Astrocyte evolution and human specificity
por: Falcone, Carmen, et al.
Publicado: (2022)

Ependymal cells and multiple sclerosis: proposing a relationship
por: Hatrock, Dale, et al.
Publicado: (2019)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

The Role of Astrocytes in Multiple Sclerosis Progression
por: Correale, Jorge, et al.
Publicado: (2015)

Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence
por: Fessel, Jeffrey
Publicado: (2021)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
por: Wu, Hao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_24amt8plbhdn9nfn6n4q7h5as5